SCHEMBL27682000

SCHEMBL27682000

NC(=O)c1ccccc1-c1ccc2cc[nH]c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.56
BTK Q06187 1/20 0.56
PI4K2A Q9BTU6 2/20 0.55
BCAT2 O15382 1/20 0.51
CHEK1 O14757 1/20 0.49
CSNK1A1 P48729 1/20 0.49
TYRO3 Q06418 1/20 0.49
DYRK1B Q9Y463 1/20 0.49
IKBKB O14920 2/20 0.48
CHUK O15111 1/20 0.47
PDPK1 O15530 1/20 0.46
MPO P05164 2/20 0.46
GHSR Q92847 2/20 0.45
RIPK2 O43353 1/20 0.44
TRPV1 Q8NER1 1/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
ENPP2 Q13822 1/20 0.44
HSD17B10 Q99714 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30369932 1.00 LCK (0.56) LCKBTKPI4K2ABCAT2CHEK1
SCHEMBL28136345 1.00 LCK (0.56) LCKBTKPI4K2ABCAT2CHEK1
SCHEMBL6997464 0.88 PI4K2A (0.55) LCKBTKPI4K2ABCAT2CHEK1
SCHEMBL28264516 0.88 PI4K2A (0.55) LCKBTKPI4K2ABCAT2CHEK1
SCHEMBL29479384 0.87 KDM4E (0.53) LCKBTKPI4K2AMPOGHSR
SCHEMBL16720498 0.87 KDM4E (0.53) LCKBTKPI4K2AMPOGHSR
SCHEMBL3425920 0.83 LCK (0.52) LCKBTKPI4K2AIKBKBCHUK
SCHEMBL29437284 0.82 PI4K2A (0.55) LCKBTKPI4K2AIKBKBCHUK
SCHEMBL30841297 0.82 SLC6A3 (0.66) LCKBTKGHSRCCNCCDK8
SCHEMBL28555350 0.80 SLC6A2 (0.49) LCKBTKPI4K2AGHSRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101605759-A 1-benzenesulfonyl-1H-indole derivatives as inhibitors of CCR9 activity NOVARTIS AG (CH) 2009-12-16 CN disclosed
CN-101035527-A Methods of treating a disorder ELIXIR PHARMACEUTICALS INC (US) 2007-09-12 CN disclosed